The Amyloid-β Pathway in Alzheimer's Disease | Molecular Psychiatry
Amyloid‐β oligomers in cellular models of Alzheimer's disease - Fontana - 2020 - Journal of Neurochemistry - Wiley Online Library
Advances in the development of new biomarkers for Alzheimer's disease | Translational Neurodegeneration | Full Text
New Alzheimer's Biomarkers may Support Early Diagnosis
Identifying and validating biomarkers for Alzheimer's disease: Trends in Biotechnology
Physiological Roles of Monomeric Amyloid-β and Implications for Alzheimer's Disease Therapeutics
Structural Dynamics of Amyloid-β Protofibrils and Actions of Anti-Amyloid-β Antibodies as Observed by High-Speed Atomic Force Microscopy | Nano Letters
Amyloid β-based therapy for Alzheimer's disease: challenges, successes and future | Signal Transduction and Targeted Therapy
Frontiers | Alzheimer's disease: a mini-review for the clinician
Biomedicines | Free Full-Text | Development of Alzheimer’s Disease Biomarkers: From CSF- to Blood-Based Biomarkers
Biomolecules | Free Full-Text | Microvascular Contributions to Alzheimer Disease Pathogenesis: Is Alzheimer Disease Primarily an Endotheliopathy?
Mechanisms of action of anti-Aβ-antibodies. Anti-Aβ-antibodies can... | Download Scientific Diagram
Nasal administration of anti-CD3 monoclonal antibody ameliorates disease in a mouse model of Alzheimer's disease | PNAS
IJMS | Free Full-Text | Potential Fluid Biomarkers for the Diagnosis of Mild Cognitive Impairment
Decreased salivary lactoferrin levels are specific to Alzheimer's disease - eBioMedicine
SARS-CoV-2 infection increases the gene expression profile for Alzheimer's disease risk: Molecular Therapy - Methods & Clinical Development
Association of B cell profile and receptor repertoire with the progression of Alzheimer's disease - ScienceDirect
IJMS | Free Full-Text | CSF Biomarkers in the Early Diagnosis of Mild Cognitive Impairment and Alzheimer’s Disease
Pro-inflammatory interleukin-6 signaling links cognitive impairments and peripheral metabolic alterations in Alzheimer's disease | Translational Psychiatry
Frontiers | Bridging the Gap Between Fluid Biomarkers for Alzheimer's Disease, Model Systems, and Patients
The complex pathway between amyloid β and cognition: implications for therapy - The Lancet Neurology
Amyloid-β (Aβ) marker expression and Aβ aggregation in the... | Download Scientific Diagram
Cerebrospinal fluid p-tau231 as an early indicator of emerging pathology in Alzheimer's disease - eBioMedicine
ADPD 2023: Alzheimer's Disease Therapeutics, Diagnostics & Mechanisms
Amyloid blood biomarker detects Alzheimer's disease | EMBO Molecular Medicine
JPM | Free Full-Text | Current Biomarkers for Alzheimer's Disease: From CSF to Blood
Comprehensive Review of Nutraceuticals against Cognitive Decline Associated with Alzheimer's Disease | ACS Omega
